From what I can gather COLVERA is insufficiently sensitive for use as a screening test for bowel cancer, it is useful in people who are known to have had the cancer to test for recurrence.
In contrast, as you know, COLOSTAT is designed as a low cost screening tool for the early and accurate detection of colorectal cancers.
Hopefully it proves to be cheap enough and accurate enough to find an enormous worldwide market!
Ann: Appendix 4C, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $29.83M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $10.72K | 92.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 148000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 4357 | 1 |
View Market Depth
| Last trade - 10.42am 11/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |